Muralidharan Jagadeesan is a Nephrology physician. OpenAlex indexes 25 publications with 851 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1120 15th St
Augusta, GA 309120004
Telephone
706-721-2861Registry record last updated 1 Nov 2012.
Clinical trials
- Plant-based Diet for Kidney Transplant Recipients
Sponsor: George Washington University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20251 payment
- Salix Pharmaceuticals, a division of Bausch Health US, LLCProgram year20252 payments
- Astellas Pharma US IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
65.3%Statin19.3%Atorvastatin Calcium42%Rosuvastatin Calcium35%Pravastatin Sodium23%Part D<11 patientsBeta blocker13.2%Carvedilol44%Labetalol Hcl19%Metoprolol Succinate18%Nebivolol Hcl18%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
18.9%Corticosteroid8.1%Prednisone100%Part D≥14 patientsProton pump inhibitor5%Pantoprazole Sodium100%Part D<11 patients+ 2 more classes in this area
Genitourinary & hormones
5.1%alpha-Adrenergic Blocker5.1%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Curious Case of De Novo Lupus Nephritis in Geriatric Patient After Kidney Transplant
Journal of the American Society of Nephrology
2023 - Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope?
Transplantation Direct
2021 - A De Novo Case of C1q Nephropathy in a Renal Allograft
Journal of the American Society of Nephrology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”